Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Reactive arthritis

Rheumatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

A hot swollen joint with systemic illness requires urgent culture, acute infection treatment and source-control assessment. Eye pain, photophobia or reduced vision needs same-day ophthalmology for possible uveitis; haemodynamic instability or disseminated gonococcal infection overrides routine rheumatology care.

Synopsis

Recognise sterile inflammatory arthritis following gastrointestinal or genitourinary infection, exclude septic and crystal arthritis, treat active infection appropriately, and review persistent disease for a wider spondyloarthritis phenotype.

  • Reactive arthritis usually begins days to several weeks after genitourinary or enteric infection and commonly causes asymmetric lower-limb oligoarthritis, enthesitis or dactylitis.
  • Ask about diarrhoea, dysuria, discharge, pelvic symptoms, sexual exposure, conjunctivitis, uveitis, oral lesions, keratoderma and heel pain without relying on the obsolete complete triad.
  • A trigger may have been mild or resolved; request infection tests according to timing, symptoms and sexual-health or public-health implications.
  • Aspirate a hot effusion for culture and crystals because septic arthritis, gonococcal infection and gout remain critical alternatives.
  • Treat confirmed active chlamydial or other infection according to current antimicrobial and partner-management guidance; antibiotics do not reliably cure established sterile arthritis after cleared enteric infection.
  • NSAIDs are commonly used for articular symptoms when safe. Intra-articular corticosteroid may help a selected joint only after infection is excluded; peri-entheseal injection needs an experienced clinician and must not enter tendon substance, particularly at the Achilles tendon.
  • Persistent peripheral arthritis warrants rheumatology reassessment. A conventional DMARD may be considered after infection is excluded, but evidence is limited and it should not be assumed to treat axial disease.
  • Provide sexual-health counselling, notification and retesting as indicated, and review for a continuing axial or peripheral spondyloarthritis phenotype.

Key red flags

Anterior uveitis

Eye pain, photophobia, redness or blurred vision requires same-day ophthalmology rather than treatment as uncomplicated conjunctivitis.

Possible gonococcal infection

Migratory pain, tenosynovitis, sparse pustules and sexual exposure requires urgent multi-site microbiology and antimicrobial assessment.

Investigation priorities

01
Synovial-fluid culture and crystalsFirst step

Exclude septic and crystal arthritis in an acutely inflamed accessible joint.

Management branches

Acute post-infectious arthritisCulture the joint and identify active infection

New lower-limb arthritis follows diarrhoea or genitourinary symptoms without haemodynamic instability.

  1. Take sexual, gastrointestinal and medicine history, examine joint, skin, eye and entheses, and aspirate any significantly hot effusion for culture and crystals.
  2. Request site-appropriate chlamydia and gonorrhoea NAAT and stool tests when indicated, while assessing sepsis and disseminated infection risk.
  3. Treat confirmed active infection through antimicrobial and partner pathways and use comorbidity-adjusted anti-inflammatory care for sterile symptoms.

Key medicines

NaproxenCommon adult dosing is 250–500 mg orally twice daily with food for a reviewed short course when clinically suitable.Assess GI ulcer or bleeding, renal, cardiovascular and anticoagulant risk; use the lowest effective dose for the shortest time with gastroprotection when indicated. Avoid from 20 weeks of pregnancy unless clinically necessary and do not use from 28 weeks; follow current MHRA and product advice.
Doxycycline for uncomplicated chlamydia100 mg orally twice daily for 7 days is the usual adult regimen, subject to current sexual-health guidance and patient factors.Doxycycline is contraindicated for routine treatment in pregnancy; the 2026 BASHH guideline permits it only when the full course finishes before 15 weeks and no suitable alternative exists. Check allergy, oesophageal irritation, photosensitivity and interactions; provide partner-notification and STI-screening support.
Open full textbook →Answer 2 questions
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CKS reactive arthritisRecognition, investigation and management in UK practice.
  • NICE NG65 spondyloarthritisPeripheral disease and acute uveitis pathways.
  • BASHH chlamydia guideline 2026Current doxycycline regimen, pregnancy exception, abstinence, partner notification and retesting.
  • UK SMI B26 sterile-site fluidsSynovial culture standards when sepsis remains possible.
  • Naproxen UK product informationAdult dose and gastrointestinal, renal and cardiovascular precautions.
  • MHRA NSAID pregnancy safetyAvoidance from 20 weeks and contraindication after 28 weeks of pregnancy.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draft
Clinical stateAwaiting review
JurisdictionUnited Kingdom